Preeti Joshi co-founded Fast Sense Innovations, developing Sep-Scan, a rapid sepsis detection device, aiming to transform ...
Sobi announces a new research collaboration on the development of Gamifant in sepsis, which is to be presented at the ISICEM congress: Stockholm Thursday, March 20, 2025, 12:00 Hr ...
The EMBRACE phase 2a trial (NCT06694701) was approved in March 2025. The first trial sites have been initiated, and patient screening to identify eligible patients with IDS has started. The EMBRACE ...
Read about the changes made to the emergency care pathway at a Buckinghamshire trust following the death of student nurse Zoe ...
SeaStar Medical has been selected to receive the 2025 Corporate Innovator Award from the National Kidney Foundation (NKF) at the 2025 Spring Clinical Meetings in ...
Abombshell media report recently exposed an official-unofficial policy at the National Institutes of Health under former director Francis Collins: Top officials conducted public business in private, ...
During a live event, Catherine J. Lee, MD, MS, discussed the efficacy and safety results of various trials of approved agents ...
Jodie Soanes initially put her daughter Lily's tiredness down to growing pains, but when her health deteriorated medics ...
The challenge here is to disentangle the various clinical pathways that may be involved. Thus, patients with severe COVID often have a sepsis-like syndrome and are transferred to intensive care units ...
Sepsis, a life-threatening condition caused by the body's dysregulated response to infection, remains a leading cause of ...
Sepsis, a life-threatening condition caused by the body's dysregulated response to infection, remains a leading cause of mortality in ICUs worldwide. Despite advancements in medical technology ...
Omega-3, omega-6, and omega-9 fatty acids provide known health benefits. A supplement may be useful, but these healthy fats ...